PET/MRI imaging in neuroendocrine neoplasm.

Autor:	Virarkar, Mayur K., Montanarella, Matthew, Itani, Malak, Calimano-Ramirez, Luis, Gopireddy, Dheeraj, Bhosale, Priya
Předmět:	NEUROENDOCRINE tumors MAGNETIC resonance imaging SOMATOSTATIN receptors PEPTIDE receptors POSITRON emission tomography COMPUTED tomography
Zdroj:	Abdominal Radiology; Dec2023, Vol. 48 Issue 12, p3585-3600, 16p
Abstrakt:	Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for evaluating NENs, ascertaining peptide receptor radionuclide therapy (PRRT) eligibility, and treatment response. SSTR-PET/MRI can provide a one-stop-shop multiparametric evaluation of NENs. The acquisition of complementary imaging information in PET/MRI has distinct advantages over PET/CT and MR imaging acquisitions. The purpose of this manuscript is to provide a comprehensive overview of PET/MRI and a current review of recent PET/MRI advances in the diagnosis, staging, treatment, and surveillance of NENs. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink